Form D · Biotechnology
AUBREY INC
Carlsbad, CA · CIK 0001451151
Offering snapshot reported Aug 31, 2009 · SEC filing
- Reported sold
- $3.88M Offering amount: $6M
- Investors reported
- 66 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Feb 1, 2008 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2009 | Initial | $3,877,920 | No comparison | 66 | SEC filing |
| Nov 25, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-124711
Source: Form D, filed Aug 31, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Goodhue Davis | Director |
| Robert Jan De Ruke | Director |
| Stephen Moss | Director, Executive |
| David Thomas Saviage | Director |
| Ernest Aubrey Woodroof | Director, Executive |
| Nancy Pearl Woodroof | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5930 Sea Lion Place, Suite 100
Carlsbad, CA, 92009
Carlsbad, CA, 92009